Genflow Biosciences PLC Announces Receipt of First Tranche of Grant

March 2, 2026 2:05 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), a leading European-based biotechnology company focusing on longevity, is pleased to confirm receipt of the first instalment of €336,467 of the previously announced €4 million non-dilutive grant awarded by the Wallonia Region of Belgium, (see RNS dated 22 October, 2024 here.)The support package spans a three-year development programme and is aligned with Genflow's...

Read more

Pure Canna Organics Revolutionizes Affordable Wellness with Premium CBD Products

February 28, 2026 6:00 AM

Pure Canna Organics is redefining the wellness industry by offering high-quality, affordable, and natural CBD products for people and pets. The company has maintained its commitment to excellence for over eight years, providing trusted solutions that support holistic well-being.Pure Canna Organics: Leading the Way in Affordable, High-Quality CBD WellnessPure Canna Organics continues to lead the way in offering accessible, plant-based wellness...

Read more

Electronic Caregiver Advances the Rio Grande Health Technology Corridor, Positioning Las Cruces as a National AI Healthcare Infrastructure Hub

February 27, 2026 7:40 PM

Electronic Caregiver, Inc., a nationally deployed AI-driven healthcare infrastructure company headquartered in Las Cruces, announced continued expansion of its operations as part of its long-term vision to build the Rio Grande Health Technology Corridor.While New Mexico has long been recognized for its national laboratories and aerospace programs, it has not historically produced a nationally scaled, consumer-integrated AI healthcare technology...

Read more

Dr. Andrea Joy Smith to Present at International Congress of Oral Implantologists 2026 Winter Implant Symposium

February 27, 2026 2:00 PM

Dr. Andrea Joy Smith, accomplished dentist, educator, and implant clinician, will present at the upcoming Winter Symposium hosted by the International Congress of Oral Implantologists (ICOI) this March in Washington, DC. The prestigious international congress brings together implant dentists from around the world for advanced continuing education, collaboration, and clinical innovation.As part of the scientific program, Dr. Smith will serve as a...

Read more

Dr. Hope Jacoby, Podiatrist, Advocates for Early Foot & Wound Care Awareness

February 27, 2026 11:45 AM

Dr. Hope Jacoby, Podiatrist and owner of Texas Wound Pros and Foot and Ankle Pros, is raising awareness of the growing risks of untreated foot and ankle conditions, particularly chronic lower-extremity wounds.With more Americans living with diabetes, vascular disease, and mobility-related conditions, foot health is becoming a critical but often overlooked issue."Foot pain is often dismissed as minor," says Dr. Jacoby. "But the feet carry the...

Read more

Saint Therese Receives Approval to Expand Corcoran Senior Community

February 27, 2026 11:40 AM

Less than two years after opening Saint Therese of Corcoran, Saint Therese is expanding its footprint in the fast-growing west metro city. Last night, the Corcoran City Council approved the new construction that will add 31 new independent living apartments to Saint Therese's existing community that currently has independent living, assisted living and memory care apartments. "We have been incredibly grateful for the warm welcome we have...

Read more

SOSOTHIN.COM Launches to Provide Fast, Affordable, and Discreet Access to GLP-1 Weight Loss and Anti-Aging Solutions

February 27, 2026 11:05 AM

Executive Digital, a global digital marketing agency, today announced the official launch of SOSOTHIN.COM, a new online destination designed to make GLP-1 weight loss and anti-aging treatments accessible to consumers through a streamlined credit card payment option that eliminates doctor's office visits, insurance, denials, and red tape.SOSOTHIN.COM was created in response to skyrocketing demand for GLP-1 medications such as Ozempic® and...

Read more

Advanced Chiropractic Equipment & Seminars Announces Initiative to Support Newly Licensed Chiropractic Graduates

February 27, 2026 11:00 AM

Advanced Chiropractic Equipment & Seminars has announced an expanded educational initiative focused on supporting newly licensed chiropractic graduates as they transition into independent practice.The initiative is designed to provide recent graduates with structured training in establishing and maintaining low-overhead, cash-based chiropractic practices. According to the organization, early-stage professional development can play a significant...

Read more

The End of "What's for Dinner?" - MDCE Launches AI App That Thinks Like a Chef! Download Snapshot Recipes Today!

February 27, 2026 9:11 AM

Medical Care Technologies, Inc. (OTC PINK:MDCE) today announced the official launch of its first consumer-based artificial intelligence mobile application, Snapshot Recipes, now available on both the Apple iOS App Store and the Google Play Store.Users can learn more and download the app at:www.snapshotrecipes.app Snapshot Recipes leverages advanced artificial intelligence to revolutionize how consumers prepare meals. The app allows users to:Take...

Read more

ZetrOZ Systems Extends Its Non-Invasive Knee Osteoarthritis Treatment to Orthopaedic Surgeons Across the United States

February 27, 2026 9:05 AM

ZetrOZ Systems will showcase its sam® sustained acoustic medicine technology's effectiveness in treating knee osteoarthritis and other musculoskeletal conditions at the annual meeting of the American Academy of Orthopaedic Surgeons, March 3-5, in New Orleans.The company will provide clinical information and demonstrate the sam® wearable ultrasound device at Booth 3612 in Hall E of the Ernest N. Morial Convention Center.ZetrOZ Systems also is...

Read more

European Medicines Agency's Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19

February 27, 2026 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending marketing authorization in the European Union for mCOMBRIAX® (mRNA-1083), Moderna's combination vaccine indicated for active immunization for the prevention of influenza and COVID-19 caused by SARS-CoV-2 in individuals 50 years of age and older."The CHMP's...

Read more

Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights

February 27, 2026 3:23 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the total issued share capital of the Company as at 27 February 2026 consists of6,425,429ordinary shares of 1p each, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 6,425,429.The figure of 6,425,429 ordinary shares may be used by shareholders of the...

Read more

BioNxt Announces Closing of Shares for Debt Settlement

February 26, 2026 7:00 PM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that, further to its news release dated January 23, 2026, the Company has issued an aggregate of 6,008,883 common shares in the capital of the Company (the "Debt Shares") at a deemed price of $0.45 per Debt Share to settle $2,704,000 in debt (the "Debt") owed to certain arm's length creditors (the "Debt Settlement"). The Debt was comprised...

Read more

Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025

February 26, 2026 4:15 PM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation to optimize health, today reported its financial results for the three and twelve months ended December 31, 2025.Corporate HighlightsAnnounced Positive Results from PRIME Clinical Study in late-stage chronic kidney disease patientsAnnounced agreement with FDA on a single adaptive Phase 2/3 study...

Read more

NHI Issues Investor Update

February 26, 2026 4:10 PM

National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at:https://investors.nhireit.com/News/presentations-and-webcasts/default.aspxAbout National Health Investors, Inc.National Health Investors, Inc. (NYSE:NHI), established in 1991 as a Maryland corporation, is a self-managed real estate investment trust ("REIT"). The Company owns, leases, operates and finances the development of high-quality real...

Read more

NHI Announces The First Quarter 2026 Dividend

February 26, 2026 4:10 PM

National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its first quarter dividend of $0.92 per common share on May 1, 2026, to stockholders of record as of March 31, 2026.About National Health Investors, Inc.National Health Investors, Inc. (NYSE:NHI), established in 1991 as a Maryland corporation, is a self-managed real estate investment trust ("REIT"). The Company owns, leases, operates and finances the development of...

Read more

NHI Announces Fourth Quarter 2025 Results

February 26, 2026 4:05 PM

National Health Investors, Inc. (NYSE:NHI) announced today its results for the fourth quarter and year ended December 31, 2025.CEO Comments"NHI generated strong financial results in 2025 that exceeded our initial NAREIT FFO, Normalized FFO and FAD guidance," said Eric Mendelsohn, NHI's President and CEO."We significantly expanded the Senior Housing Operating Portfolio ("SHOP") during 2025 from 15 properties to 26 properties. We recently...

Read more

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025

February 26, 2026 4:05 PM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company"), a biopharmaceutical company focused on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, today reported results for the three months and full year ended December 31, 2025."2025 underscored Amphastar's evolution into a company focused on both commercial strength and scientific...

Read more

MD Clarity Named to G2's 2026 Best Software Awards, Ranking in G2's Top 50 Across All Healthcare Software Categories

February 26, 2026 12:00 PM

MD Clarity, a leading provider of revenue optimization solutions, today announced it has been named to G2's 2026 Best Software Awards, earning a spot on G2's 50 Best Healthcare Software Products list. Notably, MD Clarity is one of just two Revenue Cycle Management platforms that made it onto the list.This follows MD Clarity earning two accolades as High Performer and Momentum Leader in G2's Winter 2026 Grid Report.G2's Best Software Awards rank...

Read more

Dosell Awarded Framework Agreement in Sweden's First National Procurement of Medication Dispensing Systems

February 26, 2026 10:30 AM

iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) announces that its subsidiary Dosell AB has been awarded a framework agreement in ADDA's national procurement "Medication Dispensing Systems with Remote Care Platform 2025".This marks Sweden's first national procurement of medication dispensing systems and remote care platforms. The framework agreement enables municipalities and regions across Sweden to procure Dosell's solution for safe,...

Read more